We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+7.29%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$22.1B
AUM Growth
+$302M
Cap. Flow
-$1.3B
Cap. Flow %
-5.9%
Top 10 Hldgs %
11.41%
Holding
3,562
New
1,146
Increased
641
Reduced
606
Closed
971

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$148M
2
NFLX icon
Netflix
NFLX
+$119M
3
ABNB icon
Airbnb
ABNB
+$111M
4
XYZ
Block Inc
XYZ
+$89.5M
5
DHR icon
Danaher
DHR
+$88.6M

Top Sells

Rank Stock Value
1
CRL icon
Charles River Laboratories
CRL
+$212M
2
BABA icon
Alibaba
BABA
+$172M
3
ZTS icon
Zoetis
ZTS
+$133M
4
TRU icon
TransUnion
TRU
+$124M
5
BIDU icon
Baidu
BIDU
+$111M

Sector Composition

Rank Sector Weight
1 Healthcare 20.88%
2 Financials 13.4%
3 Consumer Discretionary 12.06%
4 Technology 11.2%
5 Communication Services 8.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FTEV.WS
1251
CALL
DELISTED
FinTech Evolution Acquisition Group Redeemable Warrants, each whole warrant exercisable for one Class A Ordinary Share for $11.50 per share
FTEV.WS
$2.51M 0.01%
+260,616
New +$219K
GTX icon
1252
Garrett Motion
GTX
$5.77B
$2.51M 0.01%
+314,586
New +$2.31M
KLR
1253
DELISTED
Kaleyra, Inc.
KLR
$2.5M 0.01%
58,427
+8,162
+16% +$368K
NDLS icon
1254
Noodles & Co
NDLS
$84M
$2.5M 0.01%
25,027
-30,799
-55% -$2.87M
OUSTZ
1255
CALL
DELISTED
Ouster Inc Warrants
OUSTZ
$2.5M 0.01%
200,000
+57,975
+41% +$160K
TOI icon
1256
The Oncology Institute
TOI
$519M
$2.5M 0.01%
251,039
TMPOW
1257
CALL
DELISTED
Tempo Automation Holdings, Inc. Warrant
TMPOW
$2.49M 0.01%
249,999
+60,939
+32% +$119K
BMTX.WS
1258
CALL
DELISTED
BM Technologies, Inc. Warrants, each warrant exercisable for one share of Common Stock at an exercise price of $11.50
BMTX.WS
$2.49M 0.01%
200,000
+125,789
+170% +$276K
LITTU
1259
DELISTED
Logistics Innovation Technologies Corp. Units
LITTU
$2.49M 0.01%
+250,000
New +$2.5M
OMEG
1260
DELISTED
Omega Alpha SPAC Class A Ordinary Shares
OMEG
$2.49M 0.01%
250,000
NTRS icon
1261
Northern Trust
NTRS
$22.4B
$2.48M 0.01%
21,484
-51,036
-70% -$5.85M
XEC
1262
DELISTED
CIMAREX ENERGY CO
XEC
$2.48M 0.01%
34,286
+9,647
+39% +$652K
HLMNW
1263
CALL
DELISTED
Hillman Solutions Corp. Warrant
HLMNW
$2.48M 0.01%
+200,000
New +$439K
DCRNW
1264
CALL
DELISTED
Decarbonization Plus Acquisition Corporation II Warrant
DCRNW
$2.48M 0.01%
+250,953
New +$306K
PL icon
1265
Planet Labs
PL
$7.48B
$2.48M 0.01%
+253,375
New +$2.5M
CENHW
1266
CALL
DELISTED
Centricus Acquisition Corp. Warrant
CENHW
$2.48M 0.01%
+249,995
New +$265K
BLUE
1267
DELISTED
bluebird bio
BLUE
$2.47M 0.01%
5,971
-11,769
-66% -$4.66M
VCVCW
1268
CALL
DELISTED
10X Capital Venture Acquisition Corp Warrant
VCVCW
$2.47M 0.01%
248,048
+112,598
+83% +$181K
RAPT
1269
DELISTED
RAPT Therapeutics
RAPT
$2.46M 0.01%
+9,693
New +$1.81M
CBRL icon
1270
Cracker Barrel
CBRL
$1.17B
$2.46M 0.01%
+16,594
New +$2.67M
SMRT icon
1271
SmartRent
SMRT
$186M
$2.46M 0.01%
200,000
LOTZW
1272
CALL
DELISTED
CarLotz, Inc. Warrant
LOTZW
$2.46M 0.01%
450,000
-20,875
-4% -$32.8K
FSSI
1273
DELISTED
Fortistar Sustainable Solutions Corp. Class A Common Stock
FSSI
$2.45M 0.01%
252,034
+102,040
+68% +$998K
FVIV.WS
1274
CALL
DELISTED
Fortress Value Acquisition Corp. IV Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
FVIV.WS
$2.45M 0.01%
+249,994
New +$296K
LOKM
1275
DELISTED
Live Oak Mobility Acquisition Corp.
LOKM
$2.45M 0.01%
+249,980
New +$2.45M

Similar funds

Marshall Wace's Q2 2021 Portfolio in Review

As of Q2 2021, Marshall Wace held 3,562 positions worth $22.1B, up 1.4% from $21.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Marshall Wace withdrew a net $1.3B in Q2 2021, closing 971 positions and reducing 606 holdings. Its most notable exit was Pinterest, an estimated $88.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Marshall Wace opened a new position in West Pharmaceutical worth $55.8M.

  • Marshall Wace's largest Q2 2021 buy was West Pharmaceutical: 155,316 shares worth $55.8M.
  • Marshall Wace added most to Biogen in Q2 2021, an estimated $148M increase.
  • Marshall Wace's biggest Q2 2021 reduction was Charles River Laboratories, cutting an estimated $212M.
  • Marshall Wace fully exited Pinterest in Q2 2021, selling an estimated $88.8M.
  • Marshall Wace's ten largest holdings make up 11% of its $22.1B portfolio in Q2 2021.
  • Marshall Wace opened 1,146 new positions and closed 971 in Q2 2021.
  • Marshall Wace's portfolio value rose 1.4% quarter-over-quarter to $22.1B.

Based on Marshall Wace's 13F filing for Q2 2021, filed 13 Aug 2021.